Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy
Objective: In resource-limited countries, stavudine (d4T) is commonly used as part of the initial highly active antiretroviral therapy (HAART) regimen. Many patients who subsequently develop lipodystrophy switch from d4T to zidovudine (ZDV), a drug that can be myelotoxic. We aimed to study the spect...
Saved in:
Main Authors: | Aurpibul L., Puthanakit T., Sirisanthana T., Sirisanthana V. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-42049088552&partnerID=40&md5=4cc7941d5433e33a500b755681bc43c9 http://www.ncbi.nlm.nih.gov/pubmed/18331562 http://cmuir.cmu.ac.th/handle/6653943832/2450 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy
by: L. Aurpibul, et al.
Published: (2018) -
Recovery From Lipodystrophy in HIV-infected Children After Substitution of Stavudine With Zidovudine in a Non-nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy
by: Aurpibul L., et al.
Published: (2014) -
Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018) -
Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
by: Aurpibul L., et al.
Published: (2014) -
Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy
by: Puthanakit T., et al.
Published: (2014)